BML Drops DM Holdings Deal, Targets Rs10B Sponsor Injection

According to Mettis Link News, Bank Makramah Limited (BML) has officially terminated a potential equity investment proposal from a consortium led by DM Holdings Limited. The discussions, which originally commenced following an in-principle board approval during the 158th meeting on June 11, 2026, centered on a Letter of Interest (LOI) for a capital injection of up to Rs26 billion to acquire a significant shareholding interest.

Why the DM Holdings Consortium Deal Collapsed

Financial transactions of this magnitude rely heavily on strict regulatory conditions and thorough corporate evaluations. According to Bank Makramah Limited’s disclosures, the proposed capital injection was explicitly subject to satisfactory due diligence, successful negotiation between the involved parties, and the acquisition of all necessary corporate and regulatory approvals.

Did You Know?
Due diligence periods during major bank acquisitions often involve months of auditing assets, liabilities, and regulatory compliance before any capital is officially transferred.

Sponsor Support and Alternative Capital Injections

Even as the DM Holdings-led consortium talks concluded without a transaction, BML pursued alternative capitalization pathways. According to disclosures made to the Pakistan Stock Exchange (PSX) on August 18, 2026, the bank’s Board of Directors approved a separate investment proposal from the bank’s sponsor, Nasser Abdullah Hussain Lootah. This internal agreement outlines an injection of a further Rs10 billion into the financial institution, pending the final receipt of applicable corporate and regulatory approvals.

Key Details of BML Capital Adjustments

  • Terminated Proposal: DM Holdings Limited-led Consortium (up to Rs26bn capital injection, discussed since June 2026).
  • Current Sponsor Proposal: Nasser Abdullah Hussain Lootah (Rs10bn capital injection, approved by the board in August 2026).
  • Regulatory Stance: Both proposals remain strictly subject to corporate and regulatory clearances.

Frequently Asked Questions

What was the value of the terminated equity proposal for Bank Makramah Limited?

The proposed capital injection from the DM Holdings-led consortium was valued at up to Rs26 billion.

BML Drops DM Holdings Deal, Targets Rs10B Sponsor Injection

Who is providing the alternative capital injection for BML?

According to PSX disclosures, BML’s sponsor, Nasser Abdullah Hussain Lootah, received board approval to inject an additional Rs10 billion into the bank.

BML Drops DM Holdings Deal, Targets Rs10B Sponsor Injection

When did BML initially acknowledge the DM Holdings consortium’s interest?

BML’s Board of Directors gave in-principle approval to the consortium’s Letter of Interest during their 158th meeting held on June 11, 2026.


What are your thoughts on BML’s shifting capital strategies? Share your views in the comments below, or subscribe to our financial newsletter for continuous updates on Pakistan’s banking sector.

Leave a Comment